Publication:
Hepatic caveolin-1 is enhanced in Cyp27a1/ApoE double knockout mice

cris.virtual.author-orcid0000-0002-5125-2262
cris.virtualsource.author-orcid80a53445-481b-4f42-8014-c3bfb5ee6f2e
cris.virtualsource.author-orcidd6c65d10-607c-4422-8e88-a5f9eb203772
cris.virtualsource.author-orcid4fd2f7c2-7be6-49bb-99cb-b03db2efc9b7
datacite.rightsopen.access
dc.contributor.authorEscher, Geneviève
dc.contributor.authorZurkinden, Line
dc.contributor.authorMistry, H
dc.contributor.authorMansour, Y
dc.contributor.authorRohrbach, B
dc.contributor.authorVogt, Bruno
dc.date.accessioned2024-10-24T19:17:58Z
dc.date.available2024-10-24T19:17:58Z
dc.date.issued2016
dc.description.abstractSterol 27-hydroxylase (CYP27A1) is involved in bile acid synthesis and cholesterol homoeostasis. Cyp27a1(-/-)/Apolipoprotein E(-/-) double knockout mice (DKO) fed a western diet failed to develop atherosclerosis. Caveolin-1 (CAV-1), the main component of caveolae, is associated with lipid homoeostasis and has regulatory roles in vascular diseases. We hypothesized that liver CAV-1 would contribute to the athero-protective mechanism in DKO mice. Cyp27a1(+/+)/ApoE(-/-) (ApoE KO), Cyp27a1(+/-)/ApoE(-/-) (het), and DKO mice were fed a western diet for 2 months. Atherosclerotic plaque and CAV-1 protein were quantified in aortas. Hepatic Cav-1 mRNA was assessed using qPCR, CAV-1 protein by immunohistochemistry and western blotting. Total hepatic and plasma cholesterol was measured using chemiluminescence. Cholesterol efflux was performed in RAW264.7 cells, using mice plasma as acceptor. CAV-1 protein expression in aortas was increased in endothelial cells of DKO mice and negatively correlated with plaque surface (P < 0.05). In the liver, both CAV-1 protein and mRNA expression doubled in DKO, compared to ApoE KO and het mice (P < 0.001 for both) and was negatively correlated with total hepatic cholesterol (P < 0.05). Plasma from DKO, ApoE KO and het mice had the same efflux capacity. In the absence of CYP27A1, CAV-1 overexpression might have an additional athero-protective role by partly overcoming the defect in CYP27A1-mediated cholesterol efflux.
dc.description.numberOfPages11
dc.description.sponsorshipUniversitätsklinik für Nephrologie, Hypertonie
dc.description.sponsorshipDepartement Klinische Forschung, Forschungsgruppe Nephrologie / Hypertonie
dc.identifier.doi10.7892/boris.94886
dc.identifier.pmid28149711
dc.identifier.publisherDOI10.1002/2211-5463.12123
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/149436
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofFEBS Open Bio
dc.relation.issn2211-5463
dc.relation.organizationDCD5A442BB17E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C268E17DE0405C82790C4DE2
dc.subjectatherosclerosis
dc.subjectcholesterol efflux
dc.subjectcholesterol metabolism
dc.subjectliver
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleHepatic caveolin-1 is enhanced in Cyp27a1/ApoE double knockout mice
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage1035
oaire.citation.issue10
oaire.citation.startPage1025
oaire.citation.volume6
oairecerif.author.affiliationDepartement Klinische Forschung, Forschungsgruppe Nephrologie / Hypertonie
oairecerif.author.affiliationDepartement Klinische Forschung, Forschungsgruppe Nephrologie / Hypertonie
oairecerif.author.affiliationUniversitätsklinik für Nephrologie, Hypertonie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId94886
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
feb412123.pdf
Size:
987.26 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections